Richtech Robotics (NASDAQ:RR), a company that specializes in developing, manufacturing, and deploying robotic solutions for ...

BROADEN2 Phase 2b trial in atopic dermatitis (AD) ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma ...

The military-industrial complex is flourishing under Trump, but that doesn’t mean we can’t be optimistic about the nation’s ...

Good morning, everyone. I'm Puneet Souda. I cover life science tools and diagnostics here at Leerink. And it's my pleasure to be hosting Mike Brophy, CFO of Natera. Mike, thanks for joining us. Thanks ...

And as we lean in further, AI is strengthening our advantage, enabling significantly more automation and value for our customers, embedding our products more deeply into their daily operations and ...

At the invitation of His Excellency Narendra Modi, Prime Minister of India, the Right Honourable Mark Carney, Prime Minister of Canada, paid an official visit to India from February 27 -- March 2, ...

Hello, and welcome to today's conference call to discuss Rocket Lab USA, Inc.'s fourth quarter and full year 2025 financial results, business highlights, and other updates. At the end of Q4, our ...

Modernizing biomanufacturing methods and reducing regulatory burdens are key landmarks on India’s roadmap for expanding biosimilars development.

Senseonics Holdings, Inc. (NASDAQ:SENS) Q4 2025 Earnings Call Transcript March 2, 2026 Senseonics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.47565 EPS, expectations were ...

Editas Medicine EDIT reported a loss of 6 cents per share in the fourth quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of 27 cents. The company had incurred a loss of 55 cents ...

Major Chinese technology companies, including Tencent Holdings and TikTok's parent company ByteDance, are competing fiercely ...